Eosinophils in Asthma — Closing the Loop or Opening the Door?
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
Insulin analogues: too much noise about small benefits
Embracing ecology to limit antimicrobial resistance

Coronary Revascularization in Context
Eosinophils in Asthma — Closing the Loop or Opening the Door?
Reviewers for the Journal, July–December 2008
JUPITER Clinical Directions — Polling Results
Lose 40 pounds in 4 weeks": Regulating commercial weight-loss program

Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia

Ethics guidelines strengthened but reach remains limited
Global Transmission of Oseltamivir-Resistant Influenza
Serotonin Rising — The Bone, Brain, Bowel Connection